Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, December 2010

Sort by: Newest first Oldest first A-Z Z-A

  • SIGN releases venous thromboembolism guidance

    16 DEC 2010 13:24

    Prevention and management of venous thromboembolism are the focus of new guidance from the Scottish Intercollegiate Guidelines Network.

  • Bevacizumab rejected by NICE

    16 DEC 2010 13:21

    Bevacizumab (Avastin; Roche) has been rejected for use in the NHS by the National Institute for Health and Clinical Excellence in final guidance published today (15 December 2010).

  • NICE issues guidance on child sedation

    16 DEC 2010 13:12

    Sedatives are the focus of a new guideline from the National Institute for Health and Clinical Excellence to improve safety standards for sedating children.

  • Chained money

    NHS pay plan links increment freeze with no-redundancy promise for lower grades

    15 DEC 2010 16:15

    NHS Employers has proposed a two-year freeze on annual incremental pay rises under Agenda for Change in return for a guarantee of no compulsory redundancies for as many staff as possible. This is in addition to the two-year public sector pay freeze announced in the emergency budget earlier this year.

  • Hospital pharmacist (Diego Vito Cervo/

    2010 — Reflecting on a year of change (updated)

    15 DEC 2010 14:23

    Change has been a key theme for the pharmacy world this year. After more than three years of consultations, preparations, debates and delays, the Royal Pharmaceutical Society finally shed its regulatory functions in September and handed them to a new, independent regulator — the General Pharmaceutical Council.

  • Multiple myeloma Xray

    Triple therapy for multiple myeloma more effective than dual therapy

    15 DEC 2010 11:15

    Triple combination treatment of multiple myeloma with thalidomide, dexamethasone and bortezomib is more effective than dual therapy, a study has shown (online in The Lancet, 10 December 2010).

  • Five drugs approved for use in NHS Scotland

    15 DEC 2010 11:08

    Gefitinib (Iressa; AstraZeneca) has once again been rejected for use in NHS Scotland.

  • Saquinavir dosing recommendation in treatment-naive patients confirmed by MHRA

    15 DEC 2010 11:01

    Saquinavir should be used at half the standard dose for treatment-naive patients during the first week of therapy, the Medicines and Healthcare products Regulatory Agency’s latest Drug Safety Update confirms.

  • Pfizer logo

    Pfizer withdraws sitaxentan (Thelin)

    15 DEC 2010 10:58

    Pfizer has initiated a voluntary withdrawal of its pulmonary arterial hypertension drug Thelin (sitaxentan) in the EU, Canada and Australia following concerns about fatal liver injury. All ongoing clinical trials are also being stopped.

  • Somatropin-containing medicines to undergo safety review

    15 DEC 2010 10:48

    Medicines containing somatropin are the subject of a safety review being initiated by the European Medicines Agency.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.